Recognition of Non-Operating Income (Foreign Exchange Gain)
Medical Net,Inc. (the Group)
Monetary receivables and payables denominated in foreign currencies held by the Group
The yen's depreciation in the foreign exchange market. This was primarily attributable to the settlement and revaluation of monetary receivables and payables denominated in foreign currencies held by the Group.
¥25.973 million (consolidated accounting period for the third quarter of the fiscal year ending May 2026) and ¥104.841 million (cumulative consolidated accounting period for the third quarter of the fiscal year ending May 2026, non-operating income)
The consolidated accounting period and cumulative consolidated accounting period for the third quarter of the fiscal year ending May 2026 (1 June 2025 to 28 February 2026)
The impact on the consolidated earnings forecast for the fiscal year ending May 2026 is expected to remain within the plan announced on 18 July 2025. If any revision to the earnings outlook for the current fiscal year becomes necessary, the Company will disclose it promptly.
The impact on the consolidated earnings forecast is expected to remain within the plan. If any revision to the earnings outlook becomes necessary, the Company will disclose it promptly.
If any revision to the earnings outlook for the current fiscal year becomes necessary, the Company will disclose it promptly.
| Item | Details |
|---|---|
| Event name | Recognition of Non-Operating Income (Foreign Exchange Gain) |
| Subject Entity | Medical Net,Inc. (the Group) |
| Target Locations / Products | Monetary receivables and payables denominated in foreign currencies held by the Group |
| Cause | The yen's depreciation in the foreign exchange market. This was primarily attributable to the settlement and revaluation of monetary receivables and payables denominated in foreign currencies held by the Group. |
| Amount of Impact on Business Performance | ¥25.973 million (consolidated accounting period for the third quarter of the fiscal year ending May 2026) and ¥104.841 million (cumulative consolidated accounting period for the third quarter of the fiscal year ending May 2026, non-operating income) |
| Accounting period in which recognized | The consolidated accounting period and cumulative consolidated accounting period for the third quarter of the fiscal year ending May 2026 (1 June 2025 to 28 February 2026) |
| Impact on Earnings Forecast | The impact on the consolidated earnings forecast for the fiscal year ending May 2026 is expected to remain within the plan announced on 18 July 2025. If any revision to the earnings outlook for the current fiscal year becomes necessary, the Company will disclose it promptly. |
| Outlook | The impact on the consolidated earnings forecast is expected to remain within the plan. If any revision to the earnings outlook becomes necessary, the Company will disclose it promptly. |
| Planned follow-up disclosure | If any revision to the earnings outlook for the current fiscal year becomes necessary, the Company will disclose it promptly. |
Items this document does not state (16)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The yen's depreciation in the foreign exchange market. This was primarily attributable to the settlement and revaluation of monetary receivables and payables denominated in foreign currencies held by the Group.